|
|
| A Full-Service Solution Partner Disrupting The Outsourcing Paradigm | inSeption Group is a global full-service outsourcing organization that's resurrected a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for their clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
| The FDA Speaks Up For Quality Management: Must They Beg? | Guest Column | By Penelope Przekop, MSQA, RQAP-GCP | The FDA's quality by design (QbD) and risk-based monitoring (RBM) messaging began more than 10 years ago with their guidance on RBM. Eleven years, five total related key guidance documents (listed below), and one global pandemic later, why aren’t we moving forward at more than a snail’s pace? |
|
|
|
|
|
|
CLINICAL DATA MANAGEMENT & ANALYTICS |
|
|
|
|
|
|
| Driving Success In Dermatology Drug Development | Brochure | IQVIA Biotech | Our dedicated teams are led by in-house, board-certified dermatologists who have decades of experience conducting early- and late-phase studies. Download the available brochure to learn more. |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|